New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
May 19, 2014
05:55 EDTABTAbbott upgraded to Outperform from Neutral at Credit Suisse
Credit Suisse upgraded Abbott Laboratories to Outperform citing higher growth assumptions with the acquisition of CFR Pharmaceuticals. The firm raised its price target for shares to $46 from $44.
News For ABT From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
June 25, 2015
12:52 EDTABTEU to decide by July 29 on Mylan's bid for Perrigo, Reuters reports
Subscribe for More Information
June 18, 2015
06:09 EDTABTTeva raises stake in Mylan to 4.3%, Globes reports
Subscribe for More Information

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use